Skip to main content
Premium Trial:

Request an Annual Quote

Jerry Williamson New President of Biacore, Argeris Karabelas Becomes Board Chairman of Human Genome Sciences, William Barna Joins VizX Labs as Sales Director, and Others

Jerry Williamson has been appointed as the new president of Biacore, replacing Thomas Wida, who is leaving the company, Biacore International said on Monday. Williamson joins the Uppsala, Sweden-based company from Beacon BioPartners, a consultancy focusing on the life sciences sector. Until recently, he was the president of Pyrosequencing. Biacore said it will incur approximately SEK 3.2 million ($430,000) for the termination of Wida's contract.


 

William Barna has been named director of sales of bioinformatics software provider VizX Labs, the company said this month. Barna joins VizX Labs in this newly created position from Cytyc, where he was a district sales manager.


 

Andrea Grant has been appointed as managing director of Galadeno, the new service unit of Galapagos Genomics, the Mechelen, Belgium-based company said today. Grant used to be Galapagos' director of business development.


 

Argeris Karabelaswill become the new chairman of the board of directors of Human Genome Sciences next month, replacing William Haseltime after his retirement, the company said on Monday. Karabelas is a partner of investment firm Care Capital and has been a director of Human Genome Sciences since 2002. He holds a PhD in pharmacokinetics from the MassachusettsCollegeof Pharmacy.

In addition, Human Genome Sciences has promoted Craig Rosen to president and chief operating officer, from president for research and development. Laura D'Andrea Tyson will retire from the company's board of directors to devote more time to other responsibilities.


 

Silvano Fumero and Larry Respess have joined the board of directors of Nautilus Biotech, the Paris-based company said last week. Respess, an intellectual property lawyer, is senior vice president and general counsel of Nanogen. Fumero, who will chair the board, is CEO of Creabilis Therapeutics, a drug discovery company based in Canavese, Italy.


 

Sydney Brenner, Samuel Aparicio, and Byrappa Venkatesh of the Institute of Molecular and Cell Biology in Singaporewon the Singapore National Science Award this month for identifying the pufferfish genome as an important model for analyzing the human genome, and for their role in sequencing the whole genome of the pufferfish. Ng Huck Hui, an assistant professor at the National University of Singapore and a researcher at the Genome Institute of Singapore, won a Young Scientist Award. He was honored for his research into the function of genes in cancer.


 

Gavin MacBeath of the department of chemistry and chemical biology at HarvardUniversityhas received a grant from the W.M. Keck Foundation under the Distinguished Young Scholars in Medical Research Program. MacBeath, who has been developing protein microarrays as part of his research, plans to study protein interactions in cells. Each recipient's institution receives an award of up to $1 million to support the scientist's research activities for a period of up to five years.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.